https://www.reuters.com/business/evonik-says-recovery-unlikely-2024-plans-2000-job-cuts-2024-03-04/
https://www.indianpharmapost.com/news/evonik-university-of-mainz-to-commercialize-a-new-class-of-peg-lipids-for-nucleic-acid-delivery-15286
https://www.indianpharmapost.com/news/evonik-launches-gmp-quality-plant-based-squalene-14874
https://www.indianpharmapost.com/news/evonik-strengthens-nanoparticle-technologies-and-services-portfolio-for-parenteral-drug-delivery-14813
https://www.indianpharmapost.com/news/evonik-strengthens-nanoparticle-technologies-and-services-portfolio-for-parenteral-drug-delivery-14813
https://www.indianpharmapost.com/news/evonik-launches-eudracap-preclinic-functional-oral-capsule-for-preclinical-trials-14806
https://www.indianpharmapost.com/news/evonik-and-shandong-vland-biotech-form-jv-in-china-with-focus-on-gut-health-products-for-animals-14784
https://www.indianpharmapost.com/news/evonik-introduces-the-worlds-first-carbon-fiber-reinforced-peek-filament-for-3d-printed-medical-implants-14776
https://www.indianpharmapost.com/news/evonik-and-heraeus-cooperate-to-expand-the-range-of-services-for-highly-potent-api-14391
https://central-south-america.evonik.com/en/evonik-company-jenacell-launches-wound-dressing-epicite-balance-for-chronic-wounds-210710.html